Tiratricol-Containing Products Not Dietary Supplements - U.S. Judge
This article was originally published in The Tan Sheet
Executive Summary
Tiratricol cannot be marketed as a dietary supplement because it has been the subject of an investigational new drug application since 1990, a Cape Girardeau, Mo. federal judge has ruled in an FDA enforcement action against Syntrax Innovations.
You may also be interested in...
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
LipoKinetix should be withdrawn from the market due to reports linking the weight-loss supplement to "at least six" cases of serious liver injury, FDA states in a 1Nov. 19 letter to Chaufee, Mo.-based Syntrax Innovations
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
LipoKinetix should be withdrawn from the market due to reports linking the weight-loss supplement to "at least six" cases of serious liver injury, FDA states in a 1Nov. 19 letter to Chaufee, Mo.-based Syntrax Innovations
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
LipoKinetix should be withdrawn from the market due to reports linking the weight-loss supplement to "at least six" cases of serious liver injury, FDA states in a 1Nov. 19 letter to Chaufee, Mo.-based Syntrax Innovations